Oral Oncology
Volume 40, Issue 5 , Pages 511-519 , May 2004

OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis

  • Cathie Garnis

      Affiliations

    • British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
    • Departments of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada V6T 2B5
    • Corresponding Author InformationCorresponding author. Address: British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3. Tel.: +1-604-877-6149; fax: +1-604-877-6155
    • ,
  • Jennifer Campbell

      Affiliations

    • British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
    • ,
  • Lewei Zhang

      Affiliations

    • Oral Biological and Medical Sciences, University of British Columbia, Vancouver, BC, Canada V6T 2B5
    • ,
  • Miriam P Rosin

      Affiliations

    • British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
    • ,
  • Wan L Lam

      Affiliations

    • British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
    • Departments of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada V6T 2B5

Received 29 September 2003 ,Accepted 22 October 2003.

References 

  1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  2. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al.  Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488–2492
  3. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. New England J. Med. 2001;344:1323–1326
  4. Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck. 2001;23:238–253
  5. Partridge M, Emilion G, Falworth M, A’Hern R, Phillips E, Pateromichelakis S, et al.  Patient-specific mutation databases for oral cancer. Int. J. Cancer. 1999;84:284–292
  6. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia [comment]. Clin. Cancer Res. 2000;6:357–362
  7. Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, et al.  Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 2002;62:5295–5300
  8. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Med. 1996;2:682–685
  9. Lee JI, Soria JC, Hassan K, Liu D, Tang X, El-Naggar A, et al.  Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res. 2001;61:837–841
  10. Tanimoto K, Hayashi S, Tsuchiya E, Tokuchi Y, Kobayashi Y, Yoshiga K, et al.  Abnormalities of the FHIT gene in human oral carcinogenesis. Br. J. Cancer. 2000;82:838–843
  11. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol. 2000;36:311–327
  12. Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, et al.  Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer. 2002;34:224–233
  13. Squire JA, Bayani J, Luk C, Unwin L, Tokunaga J, MacMillan C, et al.  Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck. 2002;24:874–887
  14. Tremmel SC, Gotte K, Popp S, Weber S, Hormann K, Bartram CR, et al.  Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 2003;144:165–174
  15. Brieger J, Jacob R, Riazimand HS, Essig E, Heinrich UR, Bittinger F, et al.  Chromosomal aberrations in premalignant and malignant squamous epithelium. Cancer Genet. Cytogenet. 2003;144:148–155
  16. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 1998;20:207–211
  17. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, et al.  Assembly of microarrays for genome-wide measurement of DNA copy number. Nature Genet. 2001;29:263–264
  18. Bruder CE, Hirvela C, Tapia-Paez I, Fransson I, Segraves R, Hamilton G, et al.  High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Human Mol. Genet. 2001;10:271–282
  19. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 2000;25:144–146
  20. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer. 2004;39(1):93–98
  21. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus. A premalignant lesion?. Am. J. Pathol. 1997;151:323–327
  22. McPherson JD, Marra M, Hillier L, Waterston RH, Chinwalla A, Wallis J, et al.  A physical map of the human genome. Nature. 2001;409:934–941
  23. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, et al.  Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003;63:2872–2880
  24. Arai K, Shibahara T, Yamamoto N, Noma H. The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas. Oral Oncol. 2002;38:763–771
  25. Kayahara H, Yamagata H, Tanioka H, Miki T, Hamakawa H. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma. J. Human Genet. 2001;46:335–341
  26. Rowley H, Jones A, Spandidos D, Field J. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. Arch. Otolaryngol.––Head Neck Surg. 1996;122:497–501
  27. Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Campiglio M, et al.  The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc. Nat. Acad. Sci. USA. 1999;96:8489–8492
  28. Kannan K, Munirajan AK, Bhuvarahamurthy V, Mohanprasad BK, Shankar P, Tsuchida N, et al.  FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncol. 2000;36:189–193
  29. Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, et al.  Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res. 1999;59:4798–4803
  30. Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, et al.  Methylation of the 5’ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res. 1998;58:3429–3434
  31. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferat. 2003;36:131–149
  32. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704–707
  33. Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res. 1994;54:1617–1621
  34. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 1994;54:1152–1155
  35. van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, et al.  Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 1994;54:1156–1158
  36. Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, et al.  Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin. Cancer Res. 1999;5:4164–4174
  37. Bei R, Pompa G, Vitolo D, Moriconi E, Ciocci L, Quaranta M, et al.  Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell arcinoma. J. Pathol. 2001;195:343–348
  38. Kuo MY, Lin CY, Hahn LJ, Cheng SJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J. Oral Pathol. Med. 1999;28:165–169
  39. Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, et al.  Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol. 2002;38:235–243
  40. Huang X, Gollin SM, Raja S, Godfrey TE. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc. Nat. Acad. Sci. USA. 2002;99:11369–11374
  41. Muller D, Millon R, Velten M, Bronner G, Jung G, Engelmann A, et al.  Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur. J. Cancer. 1997;33:2203–2210
  42. Bekri S, Adelaide J, Merscher S, Grosgeorge J, Caroli-Bosc F, Perucca-Lostanlen D, et al.  Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet. Cell Genet. 1997;79:125–131
  43. Corvi R, Berger N, Balczon R, Romeo G. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma. Oncogene. 2000;19:4236–4242

PII: S1368-8375(03)00231-8

doi: 10.1016/j.oraloncology.2003.10.006

Oral Oncology
Volume 40, Issue 5 , Pages 511-519 , May 2004

Article Tools

* Image Usage & Resolution